KURA analyst estimates

Kura Oncology (KURA) analyst ratings, the average price target and its range, and every firm's latest call.

KURA analyst ratings and price targets

DateFirmCallTarget
Oct 14, 2026BarclaysKura Oncology (KURA) Reiterated at Market Outperform by Citizens on Preclinical Data for KO-7246$24.00
Oct 14, 2026Deutsche BankKura Oncology (KURA) Reiterated at Market Outperform by Citizens on Preclinical Data for KO-7246$24.00
Aug 24, 2026Raymond JamesKura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results$24.00
Aug 24, 2026Morgan StanleyKura Oncology (KURA) Reiterated at Market Outperform by Citizens Post Q2 Results$24.00
Jun 15, 2026BernsteinKura Oncology (KURA) Reiterated at Market Outperform by Citizens After Data Presentation$24.00
Jun 4, 2026Wells FargoKura Oncology (KURA) Reiterated at Market Outperform by Citizens$24.00
Jun 4, 2026CLSAKura Oncology (KURA) Reiterated at Market Outperform by Citizens$24.00
May 28, 2026JefferiesKura Oncology (KURA) Reiterated at Market Outperform by Citizens on FIT-001 Data Preview$24.00
May 28, 2026OppenheimerKura Oncology (KURA) Reiterated at Market Outperform by Citizens on FIT-001 Data Preview$24.00
Apr 14, 2026Lake StreetKura Oncology initiated with a Buy at Lake Street$23.00
Mar 13, 2026UBSKura Oncology (KURA) PT Lowered to $15 at UBS$15.00
Jan 13, 2026Leerink PartnersKura Oncology price target lowered to $20 from $25 at Leerink$20.00
Nov 24, 2025BarclaysKura Oncology price target raised to $28 from $11 at Barclays$28.00
Nov 14, 2025H.C. WainwrightH.C. Wainwright Reiterates Buy Rating on Kura Oncology (KURA)$40.00
Nov 14, 2025WedbushKura Oncology price target raised to $38 from $36 at Wedbush$38.00

Updated 2026-11-03 11:31 UTC